Cheap goods, sales gimmicks fuel WhatNot’s $11.5 billion live-shopping empire• Shopping and Style: A tech mogul’s guide to ...
Helen Bernie, DO, MPH, assistant professor of urology at Indiana University School of Medicine, will participate in an expert ...
And someone has noticed where I work – and perhaps even read this column – because another recent note sent best wishes to ...
The government disapproves of the hormone for transgender people but is enthusiastic about what it could do for cisgender men ...
Male hormones regulate bodily functioning. These chemical messengers influence energy, mood, muscle, fat, health, and overall ...
NPR's Steve Inskeep speaks with FDA Commissioner Martin Makary about the decline in testosterone in men in the U.S. and what ...
Testosterone replacement therapy (TRT) is linked to a significantly lower risk of major CV events in men with secondary hypogonadism.
At an FDA discussion of testosterone replacement therapy, a top official called for special health centers to address a ...
2d
FDA panel recommends testosterone therapy be more accessible to men, knocks ‘outdated’ restrictions
The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...
An FDA panel pushes reclassify testosterone therapy by recommending removal of controlled substance status and expanding treatment eligibility.
In the past twenty years, the number of hospitals that are capable of treating kids and adolescents has dropped significantly, according to a study published yesterday in Pediatrics. Meanwhile, the ...
MedPage Today on MSN
Expand labeling for testosterone replacement therapy, FDA panel says
Members of an FDA expert panel urged the agency to expand labeling for testosterone replacement therapy and remove its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback